drugset / Trial / NCT02052388
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of three different dosing regimens of brilacidin compared to daptomycin for the treatment of serious skin infections. This study will aid in selecting the appropriate dose of brilacidin for later stage studies.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brilacidin | Other / unclassified | 0.3 mg/kg | Intravenous |
| Subject | Brilacidin | Other / unclassified | 0.6 mg/kg | Intravenous |
| Subject | Brilacidin | Other / unclassified | 0.8 mg/kg | Intravenous |
| Comparator | Daptomycin | Other / unclassified | 4 mg/kg | Intravenous |